The role of basally synthesized nitric oxide in modulating the renal vasoconstrictor action of angiotensin II

Hypertension Research

Volumn 20, Issue 4, 1997, Pages 251-256

  Aki, Yasuharu ^a   Tomohiro, Atsufumi ^a   Nishiyama, Akira ^a   Kiyomoto, Kayo ^a   Kimura, Shoji ^a   Abe, Youichi ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Angiotensin II; NG nitro L arginine; Nitric oxide; Renal blood flow; Sodium nitroprusside

Indexed keywords

ANGIOTENSIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ARTICLE; DOG; FEMALE; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; MALE; NONHUMAN; VASOCONSTRICTION;

EID: 0031454519     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.20.251     Document Type: Article

References (28)

1. Furchgott RF, Zawadzki V: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
2. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.
3. Ito S, Johnson CS, Carretero OA: Modulation of angiotensin Il-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 1991; 87: 1656-1663.
4. Yoshida H, Tamaki T, Aki Y, Kimura S, Takenaka I, Abe Y: Effects of angiotensin II on isolated rabbit afferent arterioles. Jpn J Pharmacol 1994; 66: 457-464.
5. Alberola AM, Salazar FJ, Nakamura T, Granger JP: Interaction between angiotensin II and nitric oxide in control of renal hemodynamics in conscious dogs. Am J Physiol 1994; 267: R1472-R1478.
6. Parekh N, Dobrowolski L, Zou A-P, Steinhausen M: Nitric oxide modulates angiotensin II- and norepinephrine-dependent vasoconstriction in rat kidney. Am J Physiol 1996; 270: R630-R635.
7. Chaki S, Inagami T: New signaling mechanism of angiotensin II in neuroblastoma Neuro-2A cells: activation of soluble guanylyl cyclase via nitric oxide synthesis. Mol Pharmacol 1993; 43: 603-608.
8. 1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. Hypertension 1995; 26: 752-757.
9. 1 receptor antagonist. J Cardiovasc Pharmacol 1993; 22: 617-625.
10. Gnitro-arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilation in vitro. Br J Pharmacol 1990; 99: 408-412.
11. Smith RP, Kruszyna H: Nitroprusside produces cyanide poisoning via a reaction with hemoglobin. J Pharmacol Exp Ther 1974; 191: 557-563.
12. Aki Y, Tamaki T, Kiyomoto H, et al: Nitric oxide may participate in V2 vasopressin-receptor-mediated renal vasodilation. J Cardiovasc Pharmacol 1994; 23: 331-336.
13. Palmer RMJ, Rees DD, Ashton DS, Moncada S: L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 1988; 153: 1251-1256.
14. Rees DD, Palmer RMJ, Hodson HF, Moncada S: A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol 1989; 96: 418-424.
15. Harding JW, Cook VI, Miller-Wing AV, et al: Identification of an AII(3-8)[AIV] binding site in guinea pig hippocampus. Brain Res 1992; 583: 340-343.
16. Kurtz A, Kaissling B, Busse R, Baier W: Endothelial cells modulate renin secretion from isolated mouse juxtaglomerular cells. J Clin Invest 1991; 88: 1147-1154.
17. Gardes J, Poux J-M, Gonzalez M-F, Alhenc-Gelas F, Menard J: Decreased renin release and constant kallikrein secretion after injection of L-NAME in isolated perfused rat kidney. Life Sci 1992; 50: 987-993.
18. Johnson RA, Freeman RH: Renin release in rats during blockade of nitric oxide synthesis. Am J Physiol 1994; 266: R1723-R1729.
19. Vidai MJ, Romero JC, Vanhoutte PM: Endothelium-derived relaxing factor inhibits renin release. Eur J Pharmacol 1988; 149: 401-402.
20. Beierwaltes WH, Carretero OA: Nonprostanoid endothelium-derived. factors inhibit renin release. Hypertension 1992; 19: II-68-II-73.
21. Sigmon DH, Carretero OA, Beierwaltes WH: Endothelium-derived relaxing factor regulates renin release in vivo. Am J Physiol 1992; 263: F256-F261.
22. Bauer P, Chiu AT, Garrison JC: DuP 753 can antagonize the effects of angiotensin II in rat liver. Mol Pharmacol 1991; 39: 579-585.
23. Buga GM, Gold ME, Fukuto JM, Ignarro LJ: Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension 1991; 17: 187-193.
24. Koller A, Kaley G: Endothelial regulation of wall shear stress and blood flow in skeletal muscle microcirculation. Am J Physiol 1991; 260: H862-H868.
25. Vargas HM, Ignarro LJ, Chaudhuri G: Physiological release of nitric oxide is dependent on the level of vascular tone. Eur J Pharmacol 1990; 190: 393-397.
26. Marshall JJ, Kontos HA: Endothelium-derived relaxing factor. A perspective from in vivo data. Hypertension 1990; 16: 371-386.
27. Moncada S, Palmer RMJ, Higgs EA: NO: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-142.
28. Rapoport RM, Drazin MB, Murad F: Endothelium-dependent vasodilator and nitrovasodilator-induced relaxation may be mediated through cGMP formation and cyclic GMP-dependent protein phosphorylation. Trans Assoc Am Physicians 1983; 96: 19-30.